MCID: PTY002
MIFTS: 38

Pityriasis Versicolor

Categories: Infectious diseases, Skin diseases

Aliases & Classifications for Pityriasis Versicolor

MalaCards integrated aliases for Pityriasis Versicolor:

Name: Pityriasis Versicolor 12 56 15 17
Tinea Versicolor 45 74 64
Infection by Pityrosporum Furfur 12

Classifications:



External Ids:

Disease Ontology 12 DOID:9060
ICD9CM 36 111.0
MeSH 45 D014010
SNOMED-CT 69 56454009
ICD10 34 B36.0
UMLS 74 C0040262

Summaries for Pityriasis Versicolor

PubMed Health : 64 About tinea versicolor: Tinea versicolor, also referred to as pityriasis versicolor, is a skin condition characterized by small patches of lighter or darker skin. It is caused by a type of fungus that is found on almost everyone’s skin. It is generally not harmful and it isn't contagious.Topical treatments, such as special creams or shampoos, are usually effective.

MalaCards based summary : Pityriasis Versicolor, also known as tinea versicolor, is related to superficial mycosis and epidermodysplasia verruciformis 1. An important gene associated with Pityriasis Versicolor is CAT (Catalase). The drugs Ketoconazole and Miconazole have been mentioned in the context of this disorder. Affiliated tissues include skin and colon, and related phenotypes are Negative genetic interaction between MUS81-/- and MUS81+/+ and Negative genetic interaction between PTTG1-/- and PTTG1+/+

Disease Ontology : 12 A superficial mycosis that is a chronic, superficial fungal infection of the skin caused by Malassezia furfur, which is characterized by well-demarcated white, pink, fawn, or brownish lesions, often coalescing, and covered with thin furfuraceous scales.

Wikipedia : 77 Tinea versicolor is a condition characterized by a skin eruption on the trunk and proximal extremities. ... more...

Related Diseases for Pityriasis Versicolor

Diseases related to Pityriasis Versicolor via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 46)
# Related Disease Score Top Affiliating Genes
1 superficial mycosis 28.1 CIC KRT31 STIM1 TMC6 TMC8
2 epidermodysplasia verruciformis 1 11.5
3 epidermodysplasia verruciformis 2 11.4
4 epidermodysplasia verruciformis 3 11.4
5 papillomatosis, confluent and reticulated 11.3
6 dermatitis 10.6
7 seborrheic dermatitis 10.4
8 erythrasma 10.4
9 pityriasis rubra pilaris 10.2
10 black piedra 10.2
11 white piedra 10.2
12 papilloma 10.2
13 pityriasis rosea 10.2
14 tinea nigra 10.2
15 dermatitis, atopic 10.2
16 tinea cruris 10.2
17 dermatophytosis 10.2
18 pityriasis rotunda 10.2
19 acanthosis nigricans 10.1
20 leprosy 3 10.1
21 anxiety 10.1
22 alopecia 10.1
23 diabetes mellitus 10.1
24 ulcerative colitis 10.1
25 pain agnosia 10.1
26 colitis 10.1
27 lepromatous leprosy 10.1
28 anhidrosis 10.1
29 typhoid fever 10.1
30 dermatomycosis 10.1
31 melanoma 10.1
32 chronic mucocutaneous candidiasis 10.1
33 leishmaniasis 10.1
34 visceral leishmaniasis 10.1
35 alopecia areata 10.1
36 depression 10.1
37 multiple sclerosis 10.0
38 tetralogy of fallot 10.0
39 tinea corporis 10.0
40 tinea pedis 10.0
41 candidiasis 10.0
42 tinea favosa 10.0
43 tinea capitis 10.0
44 folliculitis 10.0
45 hansen's disease 10.0
46 lipoid proteinosis of urbach and wiethe 9.7 TMC6 TMC8

Graphical network of the top 20 diseases related to Pityriasis Versicolor:



Diseases related to Pityriasis Versicolor

Symptoms & Phenotypes for Pityriasis Versicolor

GenomeRNAi Phenotypes related to Pityriasis Versicolor according to GeneCards Suite gene sharing:

27
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Negative genetic interaction between MUS81-/- and MUS81+/+ GR00255-A-2 9.13 KRT31 TMC6 TMC8
2 Negative genetic interaction between PTTG1-/- and PTTG1+/+ GR00255-A-4 8.8 KRT31 SQLE TMC8

Drugs & Therapeutics for Pityriasis Versicolor

PubMedHealth treatment related to Pityriasis Versicolor: 64

Tinea versicolor may improve a little in cool or dry weather, but it usually doesn’t go away on its own. There are a number of effective treatments. These mainly include creams, lotions and shampoos that contain antifungal substances. They are applied to all of the affected areas of skin on the head and body. The shampoo is used too, in order to get rid of the fungus on the scalp and hair. Otherwise it might spread back to the skin again. Depending on the exact product used, it needs to be left on for anywhere from a few minutes to several hours. The products are often put on in the evening and then rinsed off in the shower the next morning.But even when treatment works, it can take up to several weeks or months for the skin patches to disappear. Only in rare cases are tablets needed.Sometimes tinea versicolor comes back again after successful treatment. If this keeps happening, doctors sometimes recommend using a special shampoo (containing an active ingredient like selenium sulfide or ketoconazole) on your skin and hair every two to four weeks. There are also oral medications (tablets) that can be taken every four weeks to prevent tinea versicolor from returning. This can greatly reduce the risk of it coming back.

Drugs for Pityriasis Versicolor (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 12)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ketoconazole Approved, Investigational Phase 4 65277-42-1 47576
2
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 1 22916-47-8 4189
3
Ciclopirox Approved, Investigational Phase 4 29342-05-0 2749
4 Cytochrome P-450 Enzyme Inhibitors Phase 4
5 Cytochrome P-450 CYP3A Inhibitors Phase 4
6 Hormones Phase 4
7 Anti-Infective Agents Phase 4,Phase 1
8 Steroid Synthesis Inhibitors Phase 4
9 Hormone Antagonists Phase 4
10 Antifungal Agents Phase 4,Phase 1
11 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4
12
Oxiconazole Approved Phase 1 64211-46-7, 64211-45-6 5361463

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Ketoconazole Foam 2% for the Treatment of Versicolor Completed NCT00830388 Phase 4 Ketoconazole 2% Foam
2 Safety Study of Ciclopirox Olamine Cream for Dermatomycoses in Children Terminated NCT01646580 Phase 4 ciclopirox
3 Clinical Assessment of Oxiconazole Nitrate Solid Lipid Nanoparticles Loaded Gel Completed NCT03823040 Phase 1 Oxiconazole Nitrate Cream 1%;Oxiconazole nitrate SLNs loaded gel.

Search NIH Clinical Center for Pityriasis Versicolor

Inferred drug relations via UMLS 74 / NDF-RT 52 :


Cochrane evidence based reviews: tinea versicolor

Genetic Tests for Pityriasis Versicolor

Anatomical Context for Pityriasis Versicolor

MalaCards organs/tissues related to Pityriasis Versicolor:

42
Skin, Colon

Publications for Pityriasis Versicolor

Articles related to Pityriasis Versicolor:

(show top 50) (show all 464)
# Title Authors Year
1
Tinea Versicolor of the Neck As Side Effect of Topical Steroids For Alopecia Areata. ( 30668183 )
2019
2
Borderline lepromatous leprosy masking as tinea versicolor. ( 30891732 )
2019
3
Erythrasmoid pityriasis versicolor with exclusive involvement of the pubis and inguinal region: report of two cases. ( 30648837 )
2019
4
Distribution of Malassezia Species from Scales of Patient with Pityriasis Versicolor by Culture in Vietnam. ( 30745953 )
2019
5
Efficacy of Azole Antifungal in Treatment of Pityriasis Versicolor. ( 30745978 )
2019
6
Malassezia species retrieved from skin with pityriasis versicolor, seborrhoeic dermatitis and skin free of lesions: a comparison of two sampling methods. ( 29505089 )
2018
7
Correction to: Antifungal activity of Myrtus communis against Malassezia sp. isolated from the skin of patients with pityriasis versicolor. ( 29294237 )
2018
8
Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical study. ( 29239242 )
2018
9
Malassezia: a case of coexisting pityriasis versicolor and Malassezia folliculitis. ( 29926112 )
2018
10
MGL_3741 gene contributes to pathogenicity of Malassezia globosa in pityriasis versicolor. ( 30106184 )
2018
11
Dermoscopy: An easy way to solve the diagnostic puzzle in pityriasis versicolor. ( 30117461 )
2018
12
MALDI-TOF MS identification of Malassezia species isolated from patients with pityriasis versicolor at the seafarers' medical service in Dakar, Senegal. ( 30340859 )
2018
13
Pityriasis versicolor with uncommon localizations: a case report. ( 30428654 )
2018
14
A Comparative Study of Efficacy and Safety of Eberconazole versus Terbinafine in Patients of Tinea Versicolor. ( 29527026 )
2018
15
The effect of tinea versicolor on thiol/disulphide homeostasis. ( 30008649 )
2018
16
Tinea Versicolor. ( 30285180 )
2018
17
Antifungal activity of Myrtus communis against Malassezia sp. isolated from the skin of patients with pityriasis versicolor. ( 29159502 )
2017
18
Recurrent and disseminated pityriasis versicolor: A novel clinical form consequent to Malassezia-host interaction? ( 29150273 )
2017
19
Narrow-band UV-B phototherapy: an effective and reliable treatment alternative for extensive and recurrent pityriasis versicolor. ( 28984153 )
2017
20
Atrophying Pityriasis Versicolor. ( 29249261 )
2017
21
Atrophic pityriasis versicolor occurring in a patient with SjAPgren's syndrome. ( 28100575 )
2017
22
Molecular and Phenotypic Identification and Speciation of Malassezia Yeasts Isolated from Egyptian Patients with Pityriasis Versicolor. ( 28969121 )
2017
23
Correction to: El-Housiny etA al., Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical study. ( 29260902 )
2017
24
Comparative efficacy of topical application of tacrolimus and clotrimazole in the treatment of pityriasis versicolor: A single blind, randomised clinical trial. ( 28120351 )
2017
25
Knowledge, perception, and practice of patients about pityriasis versicolor in Kaduna, North Central Nigeria. ( 28561308 )
2017
26
Folliculocentric tinea versicolor. ( 28329492 )
2017
27
Combined spinal epidural in a parturient with tinea versicolor. ( 29017136 )
2017
28
The evaluation of local oxidative/nitrosative stress in patients with pityriasis versicolor: a preliminary study. ( 27329971 )
2016
29
Atrophying pityriasis versicolor as an idiosyncratic TA cell-mediated response to Malassezia: A case series. ( 27816291 )
2016
30
Clinicomycological profile of pityriasis versicolor in Assam. ( 27166032 )
2016
31
Comparative clinical trial: fluconazole alone or associated with topical ketoconazole in the treatment of pityriasis versicolor. ( 27532525 )
2016
32
In vitro antifungal susceptibility of Malassezia isolates from pityriasis versicolor lesions. ( 27852993 )
2016
33
Pityriasis versicolor atrophicans mit epidermaler Atrophie. ( 27373255 )
2016
34
Comparative assessment of the efficacy of topical ketoconazole and topical luliconazole in cases of pityriasis versicolor at a tertiary care hospital in eastern India: A prospective, open, randomized controlled trial. ( 27559523 )
2016
35
Is tinea versicolor a contraindication for epidural analgesia? ( 27124308 )
2016
36
Atrophying tinea versicolor with epidermal atrophy. ( 26861589 )
2016
37
IMAGES IN CLINICAL MEDICINE. Tinea Versicolor. ( 26962748 )
2016
38
Dermoscopy as an ancillary tool for the diagnosis of pityriasis versicolor. ( 26568350 )
2015
39
Pityriasis versicolor atrophicans: Is it true atrophy or pseudoatrophy? ( 26488217 )
2015
40
SIXTEEN YEARS OF PITYRIASIS VERSICOLOR IN METROPOLITAN AREA OF PORTO ALEGRE, SOUTHERN BRAZIL. ( 26422149 )
2015
41
Neonatal pityriasis versicolor. ( 25742084 )
2015
42
Pityriasis versicolor. ( 25852089 )
2015
43
A randomized double-blind, non-inferiority Phase II trial, comparing dapaconazole tosylate 2% cream with ketoconazole 2% cream in the treatment of Pityriasis versicolor. ( 26419668 )
2015
44
A Novel Contrast Stain for the Rapid Diagnosis of Pityriasis Versicolor: A Comparison of Chicago Sky Blue 6B Stain, Potassium Hydroxide Mount and Culture. ( 26288400 )
2015
45
Study of the Distribution of Malassezia Species in Patients with Pityriasis Versicolor in Kolar Region, Karnataka. ( 26120178 )
2015
46
Antifungal Treatment for Pityriasis Versicolor. ( 29376896 )
2015
47
Influence of systemic corticotherapy on the triggering of pityriasis versicolor. ( 24724729 )
2014
48
A randomized controlled trial of combination treatment with ketoconazole 2% cream and adapalene 0.1% gel in pityriasis versicolor. ( 24802530 )
2014
49
Pityriasis versicolor: an update on pharmacological treatment options. ( 24991691 )
2014
50
Identification of Malassezia Species Isolated from Patients with Pityriasis Versicolor Using PCR-RFLP Method in Markazi Province, Central Iran. ( 26056657 )
2014

Variations for Pityriasis Versicolor

Expression for Pityriasis Versicolor

Search GEO for disease gene expression data for Pityriasis Versicolor.

Pathways for Pityriasis Versicolor

GO Terms for Pityriasis Versicolor

Cellular components related to Pityriasis Versicolor according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 intracellular membrane-bounded organelle GO:0043231 9.33 CAT CIC SQLE
2 endoplasmic reticulum membrane GO:0005789 9.26 SQLE STIM1 TMC6 TMC8
3 endoplasmic reticulum GO:0005783 9.02 CAT SQLE STIM1 TMC6 TMC8

Biological processes related to Pityriasis Versicolor according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 ion transport GO:0006811 9.13 STIM1 TMC6 TMC8
2 cholesterol metabolic process GO:0008203 8.62 CAT SQLE

Molecular functions related to Pityriasis Versicolor according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 ion channel activity GO:0005216 8.96 TMC6 TMC8
2 mechanosensitive ion channel activity GO:0008381 8.62 TMC6 TMC8

Sources for Pityriasis Versicolor

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....